Author name: Dora Campbell

Word from the President – Drew Campbell, CISSN President & Co-Founder, NiHTEK® Five years ago, NiHTEK was founded with a bold vision—to create not just another protein ingredient but to engineer a new category of protein that overcomes the limitations of both plant and dairy-based proteins. That vision became a reality with our flagship branded […]

Word from the President – Drew Campbell, CISSN President & Co-Founder, NiHTEK® Five years ago, NiHTEK® was nothing more than a bold idea—a belief that human health and performance deserved something better. The protein industry was stuck in a cycle of compromise, forcing consumers to choose between taste, digestibility, and performance. We knew there had to

Experience the NiHPRO® Protein Challenge and exclusive product launches at Sportec Tokyo 2025. Meet the NiHTEK® team and discover the future of nutrition.

Discover NiHTEK®’s groundbreaking innovations at Vitafoods Europe 2025. Participate in the NiHPRO® Protein Challenge and explore NiHPRO-Bev® and KARBFiX®—the future of performance nutrition.​

At FIBO 2025, NiHTEK®’s NiHPRO® Protein Challenge shocked attendees with taste and texture that rivaled whey—without allergens, lactose, or compromise.

At Food Matters Live UK, NiHTEK® Co-Founder Drew Campbell explains how NiHPRO® Protein Isolate is redefining protein quality with superior digestibility, DIAAS 116, and unmatched taste.

Visit NiHTEK® at FIBO 2025 in Cologne to take the NiHPRO® Protein Challenge. Experience the next generation of clean, high-performance protein.

Discover NiHTEK®’s breakthrough Hydrolyzed NiHPRO® Protein Isolate—lactose-free, allergen-free, and redefining sports nutrition in Australia and beyond.

NiHTEK® made waves at Expo West 2025 with the NiHPRO® Protein Challenge, NiHPRO-Bev® for beverages, and the energy-boosting KARBFiX® innovation.

GLP-1 users require more from their protein—and NiHPRO™ delivers. With superior digestibility, no allergens, and smoother taste than WPI90, it’s the smart choice for those on Ozempic®, Wegovy®, and other GLP-1 therapies.